ALLR - Allarity Therapeutics Inc
1.27
0.030 2.362%
Share volume: 178,188
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.24
0.03
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-05-2024 | 11-14-2024 | 05-09-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 11.969 M | 30.883 M | 20.378 M | 29.730 M | 20.796 M | |
| Current Assets | 2.295 M | 21.309 M | 20.366 M | 29.422 M | 20.466 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 110.000 K | 131.000 K | 100.000 K | 110.000 K | 113.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 312.000 K | 19.233 M | 18.463 M | 25.201 M | 16.895 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 18.000 K | 17.000 K | 12.000 K | 308.000 K | 330.000 K | |
| Other Assets | 9.656 M | 9.557 M | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 11.969 M | 30.883 M | 20.378 M | 29.730 M | 20.796 M | |
| Total liabilities | 18.440 M | 11.048 M | 7.414 M | 11.061 M | 8.785 M | |
| Total current liabilities | 18.008 M | 10.616 M | 7.414 M | 11.061 M | 8.785 M | |
| Accounts Payable | 11.058 M | 7.753 M | 4.693 M | 4.347 M | 4.602 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -7.981 M | 19.835 M | 12.964 M | 18.669 M | 12.011 M | |
| Common stock | 90.699 M | 120.288 M | 125.170 M | 140.997 M | 143.844 M | |
| Retained earnings | -98.294 M | -99.923 M | -111.513 M | -121.698 M | -126.824 M |